immune thrombocytopenia: clinical manifestation and therapy response. the interim analysis of russian register of patients with primary immune thrombocytopenia and literature review
Article Quality & Performance Metrics
Readership in this journal
SteadyRanked #16 of 24 articles by views in basic and clinical neuroscience
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
Primary immune thrombocytopenia (ITP) is a rare (orphan) blood disease. Most frequent manifestations of ITP are purpura, petechiae and bleedings with many patients have either no symptoms or minimal bleedings manifestation. The management of ITP varies widely and must be based on current international recommendations and individual assessment of clinical course. The paper presents the results of interim analysis of clinical course and therapeutic approaches in the Russian register of ITP patients with immune thrombocytopenia and literature review about ITP treatment approaches.
| Reference Key |
lisukov2014onkogematologiimmune
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;I. A. Lisukov;A. A. Maschan;A. V. Shamardina;T. V. Chagorova;I. L. Davydkin;T. M. Sycheva;T. P. Zagoskina;E. V. Karyagina;G. N. Salogub;M. T. Savinova;T. V. Shelekhova;L. G. Kovaleva;T. V. Shneyder;A. N. Unzhekova;E. E. Kuznetsova;Yu. V. Shatokhin;M. O. Ivanova;E. Yu. Vinogradova;E. M. Volodicheva;I. V. Markova;O. V. Kanyukova;K. M. Abdulkadyrov;Yu. A. Sedlova;S. M. Osyunikhina;K. D. Kaplanov;N. V. Tsvetaeva;A. R. Akhmadeev;O. S. Uspenskaya;A. D. Kulagin;N. V. Medvedeva;A. G. Rumyantsev;B. V. Afanasiev |
| Journal | basic and clinical neuroscience |
| Year | 2014 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.